Cargando…

Diet Alters Serum Metabolomic Profiling in the Mouse Model of Chronic Chagas Cardiomyopathy

Chagas disease is caused by Trypanosoma cruzi which is endemic in Latin America. T. cruzi infection results in a latent infection with approximately a third of latently infected patients developing chronic Chagas cardiomyopathy (CCM). CCM is a common cause of cardiomyopathy in endemic regions and ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lizardo, Kezia, Ayyappan, Janeesh Plakkal, Ganapathi, Usha, Dutra, Walderez O., Qiu, Yunping, Weiss, Louis M., Nagajyothi, Jyothi F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948343/ https://www.ncbi.nlm.nih.gov/pubmed/31949545 http://dx.doi.org/10.1155/2019/4956016

Ejemplares similares

Inhibition of SREBP Improves Cardiac Lipidopathy, Improves Endoplasmic Reticulum Stress, and Modulates Chronic Chagas Cardiomyopathy
por: Ayyappan, Janeesh Plakkal, et al.
Publicado: (2020)

Inhibition of ER Stress by 2-Aminopurine Treatment Modulates Cardiomyopathy in a Murine Chronic Chagas Disease Model
por: Ayyappan, Janeesh Plakkal, et al.
Publicado: (2019)

Fat tissue regulates the pathogenesis and severity of cardiomyopathy in murine chagas disease
por: Lizardo, Kezia, et al.
Publicado: (2021)

Adipose Tissue Regulates Pulmonary Pathology during TB Infection
por: Ayyappan, Janeesh Plakkal, et al.
Publicado: (2019)

Host Metabolic Changes during Mycobacterium Tuberculosis Infection Cause Insulin Resistance in Adult Mice
por: Oswal, Neelam, et al.
Publicado: (2022)

Lipid droplet-associated proteins in atherosclerosis (Review)
por: AYYAPPAN, JANEESH PLAKKAL, et al.
Publicado: (2016)

Diets Differently Regulate Tumorigenesis in Young E0771 Syngeneic Breast Cancer Mouse Model
por: Thangavel, Hariprasad, et al.
Publicado: (2023)

Diets Differently Regulate Pulmonary Pathogenesis and Immune Signaling in Mice during Acute and Chronic Mycobacterium tuberculosis Infection
por: Oswal, Neelam, et al.
Publicado: (2023)

Sex Differences in Cardiac Pathology of SARS-CoV2 Infected and Trypanosoma cruzi Co-infected Mice
por: Dhanyalayam, Dhanya, et al.
Publicado: (2022)

Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model
por: Thangavel, Hariprasad, et al.
Publicado: (2023)

Acute Chagas Disease: New Global Challenges for an Old Neglected Disease
por: Andrade, Daniela V., et al.
Publicado: (2014)

Advances in understanding the role of adipose tissue and mitochondrial oxidative stress in Trypanosoma cruzi infection
por: Nagajyothi, Jyothi F., et al.
Publicado: (2019)

T-cell receptor variable region usage in Chagas disease: A systematic review of experimental and human studies
por: de Souza-Silva, Thaiany Goulart, et al.
Publicado: (2022)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy
por: Díaz, Martha Lucía, et al.
Publicado: (2022)

The Role of Co-Stimulatory Molecules in Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018)

CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy
por: Costa, Germano Carneiro, et al.
Publicado: (2020)

Clinical Presentations of Chagas Cardiomyopathy
por: Shehadeh, Malik, et al.
Publicado: (2020)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies
por: Neves, Eula G. A., et al.
Publicado: (2022)

Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy
por: Pinto, Bruna F., et al.
Publicado: (2022)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
por: Cunha-Neto, Edecio, et al.
Publicado: (2014)

Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease
por: Koh, Carolina Cattoni, et al.
Publicado: (2023)

Editorial: Clinical and Molecular Features of Infectious Cardiomyopathies: Implications for Prevention, Treatment and Management
por: Nunes, Maria do Carmo Pereira, et al.
Publicado: (2022)

Perspectives on Adipose Tissue, Chagas Disease and Implications for the Metabolic Syndrome
por: Nagajyothi, Fnu, et al.
Publicado: (2009)

Chagas Cardiomyopathy in the Context of the Chronic Disease Transition
por: Hidron, Alicia I., et al.
Publicado: (2010)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

Chagas' disease and AIDS
por: Vaidian, Anil K, et al.
Publicado: (2004)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
por: de Souza Pimentel, Walace, et al.
Publicado: (2012)

Pathogenesis of Chagas Cardiomyopathy: Role of Inflammation and Oxidative Stress
por: Machado, Fabiana S., et al.
Publicado: (2013)

Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy
por: Romano, Minna M. D., et al.
Publicado: (2017)

Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy
por: Santacruz, David, et al.
Publicado: (2021)

Distinct CD4(−)CD8(−) (Double-Negative) Memory T-Cell Subpopulations Are Associated With Indeterminate and Cardiac Clinical Forms of Chagas Disease
por: Passos, Livia Silva Araújo, et al.
Publicado: (2021)

CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018)

Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy
por: Win, Sithu, et al.
Publicado: (2022)

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy
por: González-Alcaide, Gregorio, et al.
Publicado: (2018)

Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_abauhc9068m4b5u46s448glnpu